Industry / Belgium

Solvay Seeks Critical Mass

May 2006 | Company Finance Alert

Belgium pharmaceutical, plastics and chemicals group Solvay is seeking critical mass in its drugs division to ensure future prosperity, following the release of impressive Q106 financial

To read the full article, please take a trial.

Related Insight Articles

Omega Pharma Sells Aresus Stake To Focus On OTC Drug Market

Industry / Belgium Continuing with its aim of strengthening its core over-the-counter (OTC) medicines business, Belgium-based Omega Pharma has agreed to sell its remaining 24.0% stake in medical devices company Arseus...

November 2009

National Health Insurance Drug Expenditure Growth Declining

Industry / Belgium In response to recent press reports stating that Belgium's national health insurance scheme Inami would see a budget growth of approximately 10% in 2009, the agency has stated that it has taken steps...

September 2009

Belgian Industry Association Defends Pharmaceutical Spending

Industry / Belgium Belgium's drug industry association, pharma.be, has defended the price of medicines in the country following local reports suggesting the market is over-priced. Pharma.be also claims that Organisation...

July 2008

Janssen Workers Go On Strike

Industry / Belgium Employees at Belgium-based drugmaker Janssen Pharmaceutica (Janssen) are striking in protest at the compensation packages being offered to workers recently made redundant by US parent company Johnson...

November 2007

Becoming Health Tourism Hub

Industry / Belgium Health tourism in Belgium is on the increase as thousands of patients from around Europe flock to the country to take advantage of low treatment costs and excellent facilities. Of all the treatments...

November 2007